Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $3.62 Million - $4.53 Million
-42,185 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $3.19 Million - $3.67 Million
42,185 New
42,185 $3.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Columbus Hill Capital Management, L.P. Portfolio

Follow Columbus Hill Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbus Hill Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Columbus Hill Capital Management, L.P. with notifications on news.